Stay updated on Avatrombopag Safety & Efficacy in ITP Clinical Trial
Sign up to get notified when there's something new on the Avatrombopag Safety & Efficacy in ITP Clinical Trial page.

Latest updates to the Avatrombopag Safety & Efficacy in ITP Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.3 was added to the record history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe study record history shows a new revision entry v3.3.2 and removal of v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe header notice about a lapse in government funding was removed and replaced with the standard government disclaimer that the U.S. government does not review or approve the safety and science of listed studies. This change affects site messaging but not the trial record content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check64 days agoChange DetectedVersion 2 (2021-10-15) updates the Record History with changes to Recruitment Status and related study details (Study Status, Study Design, Contacts/Locations).SummaryDifference0.1%

- Check86 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference13%

- Check93 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

Stay in the know with updates to Avatrombopag Safety & Efficacy in ITP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avatrombopag Safety & Efficacy in ITP Clinical Trial page.